The term Patho-biotechnology ^{[1] [2] [3]}, coined by Dr Roy Sleator and Prof Colin Hill (University College Cork, Ireland) describes the exploitation of pathogenic stress survival factors in biotechnology, medicine and food.

This approach shows promise for the development of novel vaccine and drug delivery systems, as well as the design of more technologically robust and effective probiotic cultures with improved biotechnological and clinical applications.

References

1. ↑ Sleator RD and C Hill. 2007. Patho-biotechnology; using bad bugs to make good bugs better. Science Progress. 90, 1-14.
2. ↑ Sleator RD and C Hill. 2006. Patho-biotechnology; using bad bugs to do good things. Current Opinion in Biotechnology. 17, 211-216.
3. ↑ Sleator RD and Hill. 2007. 'Bioengineered Bugs' - A patho-biotechnology approach to probiotic research and applications. [doi:10.1016/j.mehy.2007.03.008]

• Science Direct

4.University of Pennsylvania in concert with Advaxis Inc. http://www.medicalnewstoday.com/articles/99624.php http://biz.yahoo.com/prnews/080428/clm057.html?.v=101